Cargando…

Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion

BACKGROUND: Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated. METHODS: In a retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamai, Yoshiko, Ohto, Hitoshi, Yasuda, Hiroyasu, Takeshita, Akihiro, Fujii, Nobuharu, Ogo, Hiroaki, Yazawa, Yurika, Hato, Takaaki, Mitani, Kinuko, Suzuki, Keijiro, Yokohama, Akihiko, Kato, Yoko, Abe, Misao, Kumagawa, Midori, Ueda, Yasunori, Nollet, Kenneth E., Cooling, Laura, Kitazawa, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518975/
https://www.ncbi.nlm.nih.gov/pubmed/34287925
http://dx.doi.org/10.1111/trf.16594
_version_ 1784584352876724224
author Tamai, Yoshiko
Ohto, Hitoshi
Yasuda, Hiroyasu
Takeshita, Akihiro
Fujii, Nobuharu
Ogo, Hiroaki
Yazawa, Yurika
Hato, Takaaki
Mitani, Kinuko
Suzuki, Keijiro
Yokohama, Akihiko
Kato, Yoko
Abe, Misao
Kumagawa, Midori
Ueda, Yasunori
Nollet, Kenneth E.
Cooling, Laura
Kitazawa, Junichi
author_facet Tamai, Yoshiko
Ohto, Hitoshi
Yasuda, Hiroyasu
Takeshita, Akihiro
Fujii, Nobuharu
Ogo, Hiroaki
Yazawa, Yurika
Hato, Takaaki
Mitani, Kinuko
Suzuki, Keijiro
Yokohama, Akihiko
Kato, Yoko
Abe, Misao
Kumagawa, Midori
Ueda, Yasunori
Nollet, Kenneth E.
Cooling, Laura
Kitazawa, Junichi
author_sort Tamai, Yoshiko
collection PubMed
description BACKGROUND: Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated. METHODS: In a retrospective, multicenter, nationwide cohort survey conducted from 2001 to 2015, alloantibody screening was performed before and after transfusion in 18,944 recipients younger than 20 years. Recipients were categorized into six cohorts based on their age at transfusion; within and among these cohorts, allo‐anti‐M was analyzed in regard to its production, persistence, and evanescence. RESULTS: In 44 patients, anti‐M detected before and/or after transfusion was an age‐related phenomenon, with a median age of 2 years and an interquartile range of 1–3 years; anti‐M was most frequently detected in a cohort of children 1 to <5 years (0.77%, 31 of 4035). At least five patients were presumed to have concurrent infections. Among 1575 adolescents/young adults (15 to <20 years), no anti‐M was detected. Of 29 patients with anti‐M prior to transfusion, the antibody fell to undetectable levels in 17 recipients (89.5%, of whom at least 13 received only M‐negative red cells) after anywhere from 5 days to 5.8 years; anti‐M persisted in 2, and was not tested in 10. Only 15 recipients (0.08%) produced new anti‐M after transfusion. CONCLUSION: Naturally occurring anti‐M is a phenomenon of younger ages, predominantly between 1 and 3 years. After transfusion, it often falls to undetectable levels.
format Online
Article
Text
id pubmed-8518975
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-85189752021-10-21 Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion Tamai, Yoshiko Ohto, Hitoshi Yasuda, Hiroyasu Takeshita, Akihiro Fujii, Nobuharu Ogo, Hiroaki Yazawa, Yurika Hato, Takaaki Mitani, Kinuko Suzuki, Keijiro Yokohama, Akihiko Kato, Yoko Abe, Misao Kumagawa, Midori Ueda, Yasunori Nollet, Kenneth E. Cooling, Laura Kitazawa, Junichi Transfusion Immunohematology BACKGROUND: Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated. METHODS: In a retrospective, multicenter, nationwide cohort survey conducted from 2001 to 2015, alloantibody screening was performed before and after transfusion in 18,944 recipients younger than 20 years. Recipients were categorized into six cohorts based on their age at transfusion; within and among these cohorts, allo‐anti‐M was analyzed in regard to its production, persistence, and evanescence. RESULTS: In 44 patients, anti‐M detected before and/or after transfusion was an age‐related phenomenon, with a median age of 2 years and an interquartile range of 1–3 years; anti‐M was most frequently detected in a cohort of children 1 to <5 years (0.77%, 31 of 4035). At least five patients were presumed to have concurrent infections. Among 1575 adolescents/young adults (15 to <20 years), no anti‐M was detected. Of 29 patients with anti‐M prior to transfusion, the antibody fell to undetectable levels in 17 recipients (89.5%, of whom at least 13 received only M‐negative red cells) after anywhere from 5 days to 5.8 years; anti‐M persisted in 2, and was not tested in 10. Only 15 recipients (0.08%) produced new anti‐M after transfusion. CONCLUSION: Naturally occurring anti‐M is a phenomenon of younger ages, predominantly between 1 and 3 years. After transfusion, it often falls to undetectable levels. John Wiley & Sons, Inc. 2021-07-21 2021-09 /pmc/articles/PMC8518975/ /pubmed/34287925 http://dx.doi.org/10.1111/trf.16594 Text en © 2021 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Immunohematology
Tamai, Yoshiko
Ohto, Hitoshi
Yasuda, Hiroyasu
Takeshita, Akihiro
Fujii, Nobuharu
Ogo, Hiroaki
Yazawa, Yurika
Hato, Takaaki
Mitani, Kinuko
Suzuki, Keijiro
Yokohama, Akihiko
Kato, Yoko
Abe, Misao
Kumagawa, Midori
Ueda, Yasunori
Nollet, Kenneth E.
Cooling, Laura
Kitazawa, Junichi
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
title Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
title_full Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
title_fullStr Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
title_full_unstemmed Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
title_short Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
title_sort allo‐anti‐m: detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
topic Immunohematology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518975/
https://www.ncbi.nlm.nih.gov/pubmed/34287925
http://dx.doi.org/10.1111/trf.16594
work_keys_str_mv AT tamaiyoshiko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT ohtohitoshi alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT yasudahiroyasu alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT takeshitaakihiro alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT fujiinobuharu alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT ogohiroaki alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT yazawayurika alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT hatotakaaki alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT mitanikinuko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT suzukikeijiro alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT yokohamaakihiko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT katoyoko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT abemisao alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT kumagawamidori alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT uedayasunori alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT nolletkennethe alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT coolinglaura alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT kitazawajunichi alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion
AT alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion